Osman Khalid Waheed is the CEO of Ferozsons Laboratories Limited. He joined the company in 1993 after obtaining his undergraduate degree from Harvard University, USA. He has worked in logistics, sales and marketing before assuming the role of company president in 1999.
During this period, the company expanded its portfolio of medical solutions for critical diseases by forging alliances with a number of leading international partners including the Boston Scientific Inc., USA the world’s leading manufacturer of medical devices, a joint venture with the Bago Group of Argentina to establish BF Biosciences Limited, Pakistan’s first biotech pharmaceutical manufacturing company and Gilead Sciences, Inc. USA for their range of Hepatitis C and anti-viral therapies to name a few.
Mr. Waheed is currently serving on the boards of a number of companies including IGI Insurance, Lahore University of Management Sciences (LUMS), Murree Brewery, Nestle Pakistan Limited, and has previously served on the boards of Trade Development Authority of Pakistan (TDAP), Pakistan Industrial Development Corporation (PIDC), and as President of the Rawalpindi Chamber of Commerce and Industries.